Discovery of SIRT7 Inhibitor as New Therapeutic Options Against Liver Cancer

Optimal therapeutic strategies for liver cancer patients remain challenging due to the high recurrence rate after surgical resection and chemotherapy resistance. Emerging evidence has shown that epigenetic factor SIRT7 is involved in various aspects of cancer biology, while inactive SIRT7 reverses h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Li, Yaqi, Liu, Bohao, Ning, Chao, Li, Yimin, Wang, Ying, Li, Zhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841758/
https://www.ncbi.nlm.nih.gov/pubmed/35174171
http://dx.doi.org/10.3389/fcell.2021.813233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841758/
https://www.ncbi.nlm.nih.gov/pubmed/35174171
http://dx.doi.org/10.3389/fcell.2021.813233

Ejemplares similares